Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Teradyne, Inc. (NYSE:TER) Going to Burn These Hedge Funds?

Is Teradyne, Inc. (NYSE:TER) going to take off soon? Money managers are getting less bullish. The number of bullish hedge fund bets shrunk by 1 lately.

To the average investor, there are many methods investors can use to track the equity markets. A pair of the most underrated are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best hedge fund managers can outpace the market by a superb margin (see just how much).

Teradyne, Inc.Just as key, positive insider trading activity is a second way to break down the financial markets. Obviously, there are plenty of stimuli for an insider to sell shares of his or her company, but only one, very clear reason why they would behave bullishly. Plenty of academic studies have demonstrated the valuable potential of this tactic if you know what to do (learn more here).

With all of this in mind, it’s important to take a look at the key action surrounding Teradyne, Inc. (NYSE:TER).

Hedge fund activity in Teradyne, Inc. (NYSE:TER)

Heading into 2013, a total of 26 of the hedge funds we track were bullish in this stock, a change of -4% from the third quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their stakes considerably.

When looking at the hedgies we track, Chuck Royce’s Royce & Associates had the most valuable position in Teradyne, Inc. (NYSE:TER), worth close to $342 million billion, accounting for 1.1% of its total 13F portfolio. On Royce & Associates’s heels is Alkeon Capital Management, managed by Panayotis æTakisÆ Sparaggis, which held a $106 million position; 0.9% of its 13F portfolio is allocated to the company. Other peers with similar optimism include Douglas Dillard Jr. and Raj D. Venkatesan’s Standard Pacific Capital, Thomas E. Claugus’s GMT Capital and Ken Fisher’s Fisher Asset Management.

Due to the fact that Teradyne, Inc. (NYSE:TER) has faced declining sentiment from the smart money, we can see that there were a few fund managers that slashed their positions entirely heading into 2013. Intriguingly, Eric Bannasch’s Cadian Capital said goodbye to the biggest investment of all the hedgies we watch, worth close to $16 million in stock.. Brian Ashford-Russell and Tim Woolley’s fund, Polar Capital, also dumped its stock, about $5 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest was cut by 1 funds heading into 2013.

How are insiders trading Teradyne, Inc. (NYSE:TER)?

Bullish insider trading is particularly usable when the company we’re looking at has experienced transactions within the past 180 days. Over the latest six-month time frame, Teradyne, Inc. (NYSE:TER) has seen zero unique insiders buying, and 5 insider sales (see the details of insider trades here).

With the returns shown by the aforementioned tactics, retail investors should always monitor hedge fund and insider trading sentiment, and Teradyne, Inc. (NYSE:TER) is an important part of this process.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!